• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Oxford Biomedica PLC

+ Add to Watchlist

OXB:LN

4.650 GBp 0.400 7.92%

As of 11:35:26 ET on 12/17/2014.

Snapshot for Oxford Biomedica PLC (OXB)

Open: 5.125 Day's Range: 4.650 - 5.125 Volume: 5,317,748
Previous Close: 5.050 52wk Range: 1.825 - 5.550 1-Yr Rtn: +125.18%

Stock Chart for OXB

No chart data available.
  • OXB:LN 4.650
  • 1D
  • 1M
  • 1Y
5.050
Interactive OXB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OXB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.0069
Est. EPS (GBP) (12/2014) -0.0020
Est. PEG Ratio -
Market Cap (M GBP) 119.29
Shares Outstanding (M) 2,565.47
30 Day Average Volume 4,514,761
Price/Book (mrq) 4.7746
Price/Sale (ttm) 8.5210
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OXB

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for OXB

Oxford BioMedica Plc is a biopharmaceutical company that specializes in the development of novel gene-based therapeutics. The Company has a focus on oncology and neurotherapy and was formed in 1995 out of Oxford University. Oxford BioMedica has facilities in Oxford, United Kingdom and San Diego, California.

John DawsonChief Executive OfficerTim WattsCFO/Secretary
Peter NolanChief Business OfficerPaul BlakeChief Development Officer
More Company Profile & Key Executives for OXB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil